(Reuters) -Cassava Sciences said it will stop all trials of its Alzheimer's disease drug after it failed a late-stage study, ...

Cancer Peptide Market Opportunity To Surpass US$ 18 Billion By 2030 Says Kuick ResearchDelhi, Nov. 25, 2024 (GLOBE NEWSWIRE) ...

(Reuters) -Cassava Sciences said on Monday it will stop all trials of its Alzheimer's disease drug after it failed a ...

Regulators need to know that our most important health care problem is not that people are taking too many prescription drugs ...

Other possible problems include heart attacks, stroke, stomachaches, internal bleeding, ulceration and skin reactions.

The Food and Drug Administration (FDA) has expanded the list of medicines exempted from value-added tax (VAT) to ensure ...

AIIMS Delhi successfully treated a stroke patient using an advanced stent-retriever device as part of the GRASSROOT clinical ...

Veterinary drug residues in animal-derived food products are considered a potential health hazard for human consumption due ...

FDA approves BridgeBio's Attruby for ATTR-CM, the first treatment labeled for near-complete stabilization of TTR in adults.

Sometimes hyped as miracle drugs, even whispered about as elixirs, semaglutide and brand-name variants such as Ozempic and ...

GLP-1 agonists, such as Ozempic, are “almost starting to look like wonder drugs,” one expert said. But do the benefits extend ...

BridgeBio Pharma Inc. jumped the most in 16 months after its drug got US regulators’ nod to treat a rare, deadly form of ...